Skip to main content
Top
Published in: Neurological Sciences 3/2020

01-03-2020 | Neuropathic Pain | Original Article

Neuropathic pain in patients with Charcot-Marie-Tooth type 1A

Authors: Bogdan Bjelica, Stojan Peric, Ivana Basta, Ivo Bozovic, Aleksandra Kacar, Ana Marjanovic, Vukan Ivanovic, Marija Brankovic, Milena Jankovic, Ivana Novakovic, Vidosava Rakocevic Stojanovic

Published in: Neurological Sciences | Issue 3/2020

Login to get access

Abstract

Background

Only several studies analyzed the characteristics of neuropathic pain (NeP) more extensively in patients with Charcot-Marie-Tooth type 1A (CMT1A). Therefore, we sought to determine the frequency and features of NeP in CMT1A patients and to assess the association between NeP and sociodemographic and clinical characteristics of patients with CMT1A.

Methods

Our research included 51 genetically diagnosed CMT1A patients. The International Association for the Study of Pain (IASP) criteria were used for diagnosis of NeP. PainDETECT questionnaire (PD-Q) was used to assess NeP features. The Medical Research Council (MRC) Sum Score, CMT Neuropathy Score (CMTNS), Overall Neuropathy Limitation Scale (ONLS) score, and Beck Depression Inventory were also used.

Results

NeP was present in 15 (29.4%) patients with CMT1A. The average intensity of pain was 5.7 ± 2.2 out of 10. The most sensitive neuropathic symptoms were numbness, then tingling, and burning sensations, while the most specific symptom was allodynia. Patients with NeP more frequently reported pain in the back (p < 0.01) and the trunk (p < 0.05). Patients with NeP had more pronounced disability of the upper extremities and overall disability, as assessed by the ONLS score (p < 0.05). Depression was more frequent in patients with NeP compared with patients without NeP (66.7 to 13.9%, p < 0.01).

Conclusion

NeP was present in almost one-third of the patients with CMT1A and it was moderate on average. Presence of NeP was associated with worse functional disability and depression.
Literature
1.
go back to reference Braathen GJ, Sand JC, Lobato A, Høyer H, Russell MB (2011) Genetic epidemiology of Charcot-Marie-Tooth in the general population. Eur J Neurol 18:39–48CrossRef Braathen GJ, Sand JC, Lobato A, Høyer H, Russell MB (2011) Genetic epidemiology of Charcot-Marie-Tooth in the general population. Eur J Neurol 18:39–48CrossRef
2.
go back to reference Saporta MA (2014) Charcot-Marie-Tooth disease and other inherited neuropathies. Continuum (MinneapMinn) 20:1208–1225 Saporta MA (2014) Charcot-Marie-Tooth disease and other inherited neuropathies. Continuum (MinneapMinn) 20:1208–1225
3.
go back to reference Jani-Ascadi, Krajewski K, Shy ME (2008) Charcot-Marie-Tooth: diagnosis and management. Semin Neurol 29:185–194CrossRef Jani-Ascadi, Krajewski K, Shy ME (2008) Charcot-Marie-Tooth: diagnosis and management. Semin Neurol 29:185–194CrossRef
4.
go back to reference Murphy SM, Laura M, Fawcett K et al (2012) Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 83:706–710CrossRef Murphy SM, Laura M, Fawcett K et al (2012) Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 83:706–710CrossRef
5.
go back to reference Lupski JR, De Oca-Luna RM, Slaugenhaupt S et al (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219–232CrossRef Lupski JR, De Oca-Luna RM, Slaugenhaupt S et al (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219–232CrossRef
6.
go back to reference Haanpää ML, Backonja MM, Bennett MI et al (2009) Assessment of neuropathic pain in primary care. Am J Med 122:13–21CrossRef Haanpää ML, Backonja MM, Bennett MI et al (2009) Assessment of neuropathic pain in primary care. Am J Med 122:13–21CrossRef
7.
go back to reference Pazzaglia C, Vollono C, Ferraro D, Virdis D, Lupi V, le Pera D, Tonali P, Padua L, Valeriani M (2010) Mechanisms of neuropathic pain in patients with Charcot-Marie Tooth 1A: a laser-evoked potential study. Pain 149:379–385CrossRef Pazzaglia C, Vollono C, Ferraro D, Virdis D, Lupi V, le Pera D, Tonali P, Padua L, Valeriani M (2010) Mechanisms of neuropathic pain in patients with Charcot-Marie Tooth 1A: a laser-evoked potential study. Pain 149:379–385CrossRef
8.
go back to reference Ribiere C, Bernardin M, Sacconi S, Delmont E, Fournier-Mehouas M, Rauscent H, Benchortane M, Staccini P, Lantéri-Minet M, Desnuelle C (2012) Pain assessment in Charcot-Marie-Tooth (CMT) disease. Ann Phys Rehabil Med 55(3):160–173CrossRef Ribiere C, Bernardin M, Sacconi S, Delmont E, Fournier-Mehouas M, Rauscent H, Benchortane M, Staccini P, Lantéri-Minet M, Desnuelle C (2012) Pain assessment in Charcot-Marie-Tooth (CMT) disease. Ann Phys Rehabil Med 55(3):160–173CrossRef
9.
go back to reference Laurà M, Hutton EJ, Blake J, Lunn MP, Fox Z, Pareyson D, Solari A, Radice D, Koltzenburg M, Reilly MM (2014) Pain and small fiber function in Charcot-Marie-Tooth disease type 1A. Muscle Nerve 50(3):366–371CrossRef Laurà M, Hutton EJ, Blake J, Lunn MP, Fox Z, Pareyson D, Solari A, Radice D, Koltzenburg M, Reilly MM (2014) Pain and small fiber function in Charcot-Marie-Tooth disease type 1A. Muscle Nerve 50(3):366–371CrossRef
10.
go back to reference Aarskog NK, Vedeler CA (2000) Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Hum Genet 107(5):494–498CrossRef Aarskog NK, Vedeler CA (2000) Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Hum Genet 107(5):494–498CrossRef
11.
go back to reference Kleyweg RP, van der Meché FG, Schmitz PI (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14(11):1103–1109CrossRef Kleyweg RP, van der Meché FG, Schmitz PI (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14(11):1103–1109CrossRef
12.
go back to reference Shy ME, Blake J, Krajewski K et al (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64(7):1209–1214CrossRef Shy ME, Blake J, Krajewski K et al (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64(7):1209–1214CrossRef
13.
go back to reference Graham R, Hughes R (2006) A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 77(8):973–976CrossRef Graham R, Hughes R (2006) A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 77(8):973–976CrossRef
14.
go back to reference Beck AT, Steer RA, Carbin MG (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8(1):77–100CrossRef Beck AT, Steer RA, Carbin MG (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8(1):77–100CrossRef
15.
go back to reference Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70(18):1630–1635CrossRef Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70(18):1630–1635CrossRef
16.
go back to reference Freynhagen R, Baron R, Gockel U, Tölle TR (2006) painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22(10):1911–1920CrossRef Freynhagen R, Baron R, Gockel U, Tölle TR (2006) painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22(10):1911–1920CrossRef
17.
go back to reference Carter GT, Jensen MP, Galer BS, Kraft GH, Crabtree LD, Beardsley RM, Abresch RT, Bird TD (1998) Neuropathic pain in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 79:1560–1564CrossRef Carter GT, Jensen MP, Galer BS, Kraft GH, Crabtree LD, Beardsley RM, Abresch RT, Bird TD (1998) Neuropathic pain in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 79:1560–1564CrossRef
18.
go back to reference Ramchandren S, Jaiswal M, Feldman E, Shy M (2014) Effect of pain in pediatric inherited neuropathies. Neurology 82(9):793–797CrossRef Ramchandren S, Jaiswal M, Feldman E, Shy M (2014) Effect of pain in pediatric inherited neuropathies. Neurology 82(9):793–797CrossRef
19.
go back to reference Jensen MP, Abresch RT, Carter GT, McDonald CM (2005) Chronic pain in persons with neuromuscular disease. Arch Phys Med Rehabil 86(6):1155–1163CrossRef Jensen MP, Abresch RT, Carter GT, McDonald CM (2005) Chronic pain in persons with neuromuscular disease. Arch Phys Med Rehabil 86(6):1155–1163CrossRef
20.
go back to reference Abresch RT, Carter GT, Jensen MP, Kilmer DD (2002) Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Med 19:39–48CrossRef Abresch RT, Carter GT, Jensen MP, Kilmer DD (2002) Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Med 19:39–48CrossRef
21.
go back to reference Tiffreau V, Viet G, Thevenon A (2006) Pain and neuromuscular disease. Am J Phys Med Rehabil 85(9):756–766CrossRef Tiffreau V, Viet G, Thevenon A (2006) Pain and neuromuscular disease. Am J Phys Med Rehabil 85(9):756–766CrossRef
22.
go back to reference Singleton JR (2005) Evaluation and treatment of painful peripheral polyneuropathy. Semin Neurol 25:185–195CrossRef Singleton JR (2005) Evaluation and treatment of painful peripheral polyneuropathy. Semin Neurol 25:185–195CrossRef
23.
go back to reference Van Paassen B, Van der Kooi A, Spaendonck-Zwarts VK, Verhamme C, Baas F, De Visser M (2014) PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies. Orphanet J Rare Dis 9:38CrossRef Van Paassen B, Van der Kooi A, Spaendonck-Zwarts VK, Verhamme C, Baas F, De Visser M (2014) PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies. Orphanet J Rare Dis 9:38CrossRef
24.
go back to reference Liao JP, Waclawik AJ (2004) Nerve root hypertrophy in CMT type 1A. Neurology 62(5):783CrossRef Liao JP, Waclawik AJ (2004) Nerve root hypertrophy in CMT type 1A. Neurology 62(5):783CrossRef
25.
go back to reference Argoff CE (2007) The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain 23(1):15–22CrossRef Argoff CE (2007) The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain 23(1):15–22CrossRef
Metadata
Title
Neuropathic pain in patients with Charcot-Marie-Tooth type 1A
Authors
Bogdan Bjelica
Stojan Peric
Ivana Basta
Ivo Bozovic
Aleksandra Kacar
Ana Marjanovic
Vukan Ivanovic
Marija Brankovic
Milena Jankovic
Ivana Novakovic
Vidosava Rakocevic Stojanovic
Publication date
01-03-2020
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 3/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-04142-5

Other articles of this Issue 3/2020

Neurological Sciences 3/2020 Go to the issue